We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
CALL
ConocoPhillips
COP
$182B
| $904K | ﹤0.01% |
+8,700
| New | +$1.03M |
2026 Q2
0 quarters
|
|
2227
Nano X Imaging
NNOX
$27M
| $903K | ﹤0.01% |
+778,417
| New | +$1.46M |
2026 Q2
0 quarters
|
|
2228
National Healthcare
NHC
$3.5B
| $900K | ﹤0.01% |
+4,259
| New | +$782K |
2026 Q2
0 quarters
|
|
2229
Sabine Royalty Trust
SBR
$1.07B
| $898K | ﹤0.01% |
12,271
-46,572
| -79% | -$3.51M |
2026 Q1
1 quarter
|
|
2230
NervGen Pharma
NGEN
$153M
| $898K | ﹤0.01% |
435,962
+235,603
| +118% | +$731K |
2026 Q1
1 quarter
|
|
2231
CALL
iShares MSCI EAFE ETF
EFA
$76.4B
| $893K | ﹤0.01% |
+8,600
| New | +$885K |
2026 Q2
0 quarters
|
|
2232
Armour Residential REIT
ARR
$1.79B
| $893K | ﹤0.01% |
51,164
-672,356
| -93% | -$11.6M |
2025 Q2
4 quarters
|
|
2233
Build-A-Bear
BBW
$293M
| $890K | ﹤0.01% |
29,089
-42,592
| -59% | -$1.53M |
2024 Q3
7 quarters
|
|
2234
Resources Connection
RGP
$92.3M
| $889K | ﹤0.01% |
+209,243
| New | +$879K |
2026 Q2
0 quarters
|
|
2235
PUT
Agnico Eagle Mines
AEM
$89B
| $884K | ﹤0.01% |
5,700
+1,900
| +50% | +$352K |
2025 Q4
2 quarters
|
|
2236
HealthStream
HSTM
$1.07B
| $882K | ﹤0.01% |
32,376
| – | – |
2026 Q1
1 quarter
|
|
2237
Cognex
CGNX
$9.36B
| $879K | ﹤0.01% |
12,136
-66,555
| -85% | -$4.04M |
2025 Q2
4 quarters
|
|
2238
Brookfield Asset Management
BAM
$75.1B
| $879K | ﹤0.01% |
+19,589
| New | +$925K |
2026 Q2
0 quarters
|
|
2239
Endava
DAVA
$108M
| $878K | ﹤0.01% |
310,181
-84,857
| -21% | -$313K |
2025 Q3
3 quarters
|
|
2240
Kite Realty
KRG
$4.94B
| $878K | ﹤0.01% |
30,929
+18,529
| +149% | +$498K |
2026 Q1
1 quarter
|
|
2241
PUT
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $876K | ﹤0.01% |
+4,600
| New | +$786K |
2026 Q2
0 quarters
|
|
2242
SR Bancorp
SRBK
$139M
| $875K | ﹤0.01% |
+44,465
| New | +$822K |
2026 Q2
0 quarters
|
|
2243
Innovative Industrial Properties
IIPR
$1.48B
| $875K | ﹤0.01% |
+14,116
| New | +$793K |
2026 Q2
0 quarters
|
|
2244
Sequans Communications SA
SQNS
$37.1M
| $874K | ﹤0.01% |
257,194
+24,546
| +11% | +$82.1K |
2025 Q3
3 quarters
|
|
2245
GATX Corp
GATX
$5.88B
| $874K | ﹤0.01% |
+4,933
| New | +$898K |
2026 Q2
0 quarters
|
|
2246
Bristol-Myers Squibb
BMY
$126B
| $874K | ﹤0.01% |
15,169
-3,674,669
| -100% | -$211M |
2025 Q2
4 quarters
|
|
2247
PUT
Humana
HUM
$50.1B
| $874K | ﹤0.01% |
2,200
-2,400
| -52% | -$683K |
2025 Q3
3 quarters
|
|
2248
Pediatrix Medical
MD
$2.36B
| $872K | ﹤0.01% |
+34,428
| New | +$783K |
2026 Q2
0 quarters
|
|
2249
Mesa Laboratories
MLAB
$727M
| $870K | ﹤0.01% |
+8,740
| New | +$880K |
2026 Q2
0 quarters
|
|
2250
Costamare Bulkers Holdings
CMDB
$490M
| $869K | ﹤0.01% |
49,515
-7,344
| -13% | -$128K |
2026 Q1
1 quarter
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.